Adicon Holdings Limited risk profile
61 Stretched several inputs deteriorating together
Measured 21 October 2026 from 9860.HK's filed statements. Recomputed nightly.
61 (Stretched), driven by Market expectation at 76, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 76 | Stretched | Volatile | One-year price volatility — 71.2% |
| Operating pressure | 60 | Stretched | Worsening | Operating-margin drift — -12.6 percentage points |
| Cash conversion | 30 | Normal | Stable | Capital spending against operating cash — 0.48x |
| Leverage and coverage | 56 | Elevated | Worsening | Net debt to EBITDA — 5.19x |
| Competitive position | 68 | Stretched | Stable | Revenue-growth gap against peers — -72.4 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Healthcare companies with a risk reading
Lilly(Eli) & Company 33Johnson & Johnson 39Abbvie Inc 57Unitedhealth Group Inc 43Roche Holding AG 35Merck & Co Inc 35Novartis AG 29Novartis AG 31Astrazeneca plc 33Thermo Fisher Scientific Inc 44AMGEN Inc 47Gilead Sciences Inc 51
Financials, valuation and price history for Adicon Holdings Limited